Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Alteplase For Inj 100 Mg (CDM Rx50242008527) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 11, 2026 , from http://ppman.hank.ai/transparency/procedure/Rx50242008527/by-state?code_type=CDM
“Alteplase For Inj 100 Mg (CDM Rx50242008527) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/Rx50242008527/by-state?code_type=CDM. Accessed
October 11, 2026 .
“Alteplase For Inj 100 Mg (CDM Rx50242008527) by State,” HANK Price Transparency ,
accessed October 11, 2026 ,
http://ppman.hank.ai/transparency/procedure/Rx50242008527/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
Rx50242008527 — Alteplase For Inj 100 Mg
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$20,936
National median
$19,889 – $20,936
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for Rx50242008527 (CDM), with interquartile range
State Median p25 p75
WA $20,936 $19,889 $20,936